RAPT Therapeutics (RAPT) Other financing activities (2020 - 2024)
Historic Other financing activities for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to $4.6 million.
- Therapeutics' Other financing activities rose 361.26% to $4.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $19.9 million, marking a year-over-year increase of 1664.03%. This contributed to the annual value of $19.9 million for FY2024, which is 1664.03% up from last year.
- Therapeutics' Other financing activities amounted to $4.6 million in Q4 2024, which was up 361.26% from $4.6 million recorded in Q3 2024.
- Therapeutics' Other financing activities' 5-year high stood at $5.4 million during Q1 2024, with a 5-year trough of $2.0 million in Q3 2020.
- Moreover, its 5-year median value for Other financing activities was $2.9 million (2021), whereas its average is $3.3 million.
- As far as peak fluctuations go, Therapeutics' Other financing activities plummeted by 1845.19% in 2021, and later skyrocketed by 5864.52% in 2023.
- Quarter analysis of 5 years shows Therapeutics' Other financing activities stood at $2.6 million in 2020, then decreased by 18.45% to $2.1 million in 2021, then surged by 45.01% to $3.0 million in 2022, then skyrocketed by 46.41% to $4.4 million in 2023, then rose by 3.61% to $4.6 million in 2024.
- Its Other financing activities stands at $4.6 million for Q4 2024, versus $4.6 million for Q3 2024 and $5.4 million for Q2 2024.